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Tuesday, September 14, 2021 
 
 
During this COVID-19 pandemic and other future events, the CDM has been 
and will continue to be a source of reliable information, education and models 
for mitigation, preparedness, response, and recovery.  We hope this 
informational document has helped provide you filtered and actionable 
information.  As the pace of new information and changes occur, we will 
evaluate the current once per week to determine if this information should be 
provided on a more frequent basis.   
 
 
                                                                                                                        
David Markenson, M.D., M.B.A. 
Director 










 Total Cases Total Deaths Total Vaccine 
Doses Admin. 
Worldwide 225,433,571 4,642,727 5,736,390,591 
United States 41,229,958 662,378 379,527,940 
New Jersey 1,119,051 27,079 11,414,084 
New York 2,340,950 54,672 25,056,930 
Connecticut 380,281 8,424 4,912,621 
 
Information as of 9/14/21 at 1100 EDT. Source: https://coronavirus.jhu.edu/map.html  
 





Center for Disaster Medicine Updates 
 
• Coordinating and overseeing COVID-19 screenings at NYMC campus 
• Continue to partner with local organizations such as Westchester Department of Emergency 
Services and Westchester Medical Center to ensure ongoing collaboration with all public 
safety agencies. 
• Coordinating volunteers to support local public health response to COVID-19. 
• Conducting research and analysis of current events and COVID-19 response to identify 
strengths and areas for improvement in other regions. 
• Updating and developing new programs to provide enhanced education on public health 
emergencies including pandemics. 
• Exploring course development opportunities in infection prevention and control for frontline 
responders in the hospital and in the field. 
• Serving as a source of information for COVID-19 related concerns or questions regarding 
public health, emergency medical service (EMS), public safety and healthcare response. 
• Local networking and pandemic response analysis for New York’s tri-state area, using first-
person experiences to highlight current trends. 
 
To view the Center for Disaster Medicine's newest webinar, please click here - The 





The White  
 
On September 10, 2021, White House COVID- ⁠19 Response Team and Public Health Officials 
provided an update regarding COVID-19. Drs. Walensky, Fauci, and Murthy provided the current 




On September 9, 2021, President Biden addressed the nation and provided an update regarding 




The official website of the White House will deliver updated information as the country grapples 
with converging crises. This will include actions to control the COVID-19 pandemic, provide 
economic relief, tackle climate change, and advance racial equity and civil rights, as well as 
immediate actions to reform our immigration system and restore America’s standing in the world. 




Health and Human Services (HHS) 
 
On September 10, 2021, the U.S. Department of Health and Human Services (HHS), through 
the Centers for Medicare & Medicaid Services (CMS), announced that it is awarding $20 million 
in American Rescue Plan (ARP) grant funding to State-based Marketplaces (SBMs) to increase 
consumer access to affordable, comprehensive health insurance coverage. The grants will be 
used by 21 SBMs to modernize IT systems and/or conduct targeted consumer outreach activities 
to help make health care coverage enrollment smoother. As a result, consumers will have 




On September 10, 2021, the Biden-Harris Administration announced that the U.S. Department of 
Health and Human Services (HHS), through the Health Resources and Services Administration 
(HRSA), is making $25.5 billion in new funding available for health care providers affected by the 
COVID-19 pandemic. This funding includes $8.5 billion in American Rescue Plan (ARP) 
resources for providers who serve rural Medicaid, Children's Health Insurance Program (CHIP), 
or Medicare patients, and an additional $17 billion for Provider Relief Fund (PRF) Phase 4 for a 







United States Food and Drug Administration (FDA) 
 
As of September 10, 2021,  409 tests and sample collection devices are authorized by the 
FDA under emergency use authorizations (EUAs). These include 287 molecular tests and 
sample collection devices, 88 antibody and other immune response tests and 34 antigen 
tests. There are 62 molecular authorizations and one antibody authorization that can be 
used with home-collected samples. There is one molecular prescription at-home test, 
three antigen prescription at-home tests, seven antigen over-the-counter (OTC) at-home 
tests and two molecular OTC at-home tests. The FDA has authorized 14 antigen tests 
 
For the latest COVID-19 information from HHS 
https://www.hhs.gov/about/news/coronavirus/index.html 
 
National Institutes of Health (NIH)  
 
View the latest COVID-19 information from NIH 
https://www.nih.gov/coronavirus  
 
and eight molecular tests for serial screening programs. The FDA has also authorized 632 








Centers for Disease Control and Prevention (CDC) 
On September 2, 2021, CDC provided updated guidance regarding COVID-19 Vaccines 
for Moderately to Severely Immunocompromised People. CDC continues to recommend 
the use of the newly FDA-approved Pfizer-BioNTech (COMIRNATY) COVID-19 Vaccine 
for people 16 years and older, as one of the recommended vaccines to protect against 
COVID-19. CDC continues to recommend the vaccine under an emergency use 
authorization (EUA) for adolescents 12 through 15 years old, as well as an additional 
mRNA dose for moderately to severely immunocompromised people.   
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html  
 
On August 31, 2021, CDC launched COVID-19 resources for people with intellectual and 
developmental disabilities. The COVID-19 pandemic has created unique challenges for 
people with intellectual and developmental disabilities (IDD). To address them, the 
Centers for Disease Control and Prevention (CDC) created a COVID-19 toolkit with 
communication resources explaining in plain language how people with IDD and 
caregivers can protect themselves from the virus. 
https://www.cdc.gov/media/releases/2021/p0831-cdc-launches-covid-19-resources.html  
 
CDC provides updated information about the variants in the United States- The emerging 
variants CDC is closely monitoring have mutations in the virus genome that alter the 
characteristics and cause the virus to act differently in ways that are significant to public 
health (e.g., causes more severe disease, spreads more easily between humans, 
requires different treatments, changes the effectiveness of current vaccines). It’s 
important to understand that genetic mutations are expected, and some variants can 
spread and become predominant while others subside. 
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html  
 
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and 
trends of COVID-19 in the United States- updated daily by 8 p.m. ET. 
https://covid.cdc.gov/covid-data-tracker/#datatracker-home  
 
For the latest CDC information 
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html 
 
Center for Medicare and Medicaid Services (CMS)   
On September 9, 2021, the Biden-Harris Administration announced that it will require 
COVID-19 vaccination of staff within all Medicare and Medicaid-certified facilities to 
protect both them and patients from the virus and its more contagious Delta variant.  
Facilities across the country should make efforts now to get health care staff vaccinated to 










In this section, vaccine-related information from various sources will be collected, 
reviewed, and tabulated here.  As of September 14, 2021, the FDA has granted 
Emergency Use Authorization (EUA) to Moderna and Janssen/Johnson & Johnson. On 
August 23, 2021, the FDA granted full approval to Pfizer. Now with two vaccines with EUA 
and one vaccine with full FDA approval, the goal is to vaccinate a larger number of 
persons in the coming months throughout the United States. As additional vaccines are 
granted EUA, information for those vaccines will also be included. 
CDC created this section regarding COVID-19 vaccinations in the United States- CDC 
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and 
data updated daily by 8 PM. This section represents all vaccine partners including 
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal 
Emergency Management Agency and Health Resources and Services Administration 
partner sites, and federal entity facilities.  
https://covid.cdc.gov/covid-data-tracker/#vaccinations  
 
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the 
distribution of the vaccine including the number of doses received by the state, a 
breakdown of first or second doses, and the number of persons vaccinated with the first 
and second doses in each region. 
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker  
 
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide 
updated relevant information including side effects and safety data, clinical trials 
demographic statistics, and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html  
 
CDC created this section regarding the Moderna vaccine to provide updated relevant 
information including side effects and safety data, clinical trials demographic statistics, 
and information on how the vaccine works. 
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html   
 
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated 
relevant information including side effects and safety data, clinical trials demographic 




HHS created this section to provide the latest information about COVID-19 vaccines. 
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html  
For NYC DOHMH updated guidance regarding COVID-19 vaccine 
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page  
 
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19 
vaccination location. The Vaccine Finder can also provide New Yorkers with information 
to schedule vaccination appointments. 
https://vaccinefinder.nyc.gov/  
 
Educational Institution Information 
• Higher Education 
o President Biden announced new actions the administration is taking to 
get unvaccinated individuals to take the COVID-19 shot, and while last 
week’s announcement is bound to impact colleges and universities, the 
extent to which is still unclear. Biden announced the Department of Labor 
is developing new emergency regulations that will require all private 
sector businesses with more than 100 employees to require their 
workforce to get vaccinated. Employers will have to provide paid time off 
for employees to get vaccinated. If an employee still chooses to remain 
unvaccinated, they must produce a negative COVID-19 test at least once 




o Governor Kathy Hochul announced the launch of the multi-faceted statewide 
#VaxtoSchool campaign to support increasing COVID-19 vaccination rates 
among school-aged New Yorkers, furthering the administration's commitment to 
making the health and well-being of students, teachers and families a top 
priority. As part of this campaign, the Governor announced a new, 
dedicated website at ny.gov/vaxtoschool with critical resources and materials for 






To view the latest information on clinical trials regarding COVID-19 
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=  











• Governor Kathy Hochul announced the opening of New York's new $40 million 
Biodefense Commercialization Fund. The program will accelerate the development and 
commercialization of life science research and innovations that address serious 
infectious health threats, including COVID-19 and its variants—an issue of growing 
urgency given the recent uptick in cases across the nation. "The Biodefense 
Commercialization Fund will help the next generation of startups and early-stage 
companies combat infectious diseases while creating jobs and investment in New York's 
life science industry. We want to ensure that New York is where these groundbreaking 
companies start and operate, and that our state is at the center of the search for 
solutions to the world's most pressing problems." 
https://www.governor.ny.gov/news/governor-hochul-announces-opening-new-york-




New York State Department of Health (DOH) 
 
On September 13, 2021, Governor Hochul updated New Yorkers on the state's progress 
combating COVID-19.  "We are continuing to closely monitor the numbers across the state and 
working with localities to identify hotspots and dispatch resources as necessary," Governor 
Hochul said. "We all want to put COVID-19 behind us, but the reality is we still have more work 
to do — and we need to stay vigilant. The vaccine is still our greatest weapon in this fight, and 
those who are still unvaccinated need to understand the power they have in their hands to help 








NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information 
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down 










• Despite uncertainty surrounding the need for COVID booster shots, New Jersey officials 
said that they are preparing to open three of the state's megasites with as many as 2.4 
million residents becoming immediately eligible for the shot under President Joe Biden 
preliminary plan. Governor Phil Murphy cautioned that there would likely not be enough 





• Governor Ned Lamont announced that the Connecticut Office of Tourism is launching a 
new fall marketing campaign to promote safe travel and fuel the Connecticut tourism 
industry’s continued economic recovery from the COVID-19 pandemic. Called “Full 
Color Connecticut,” the campaign features the state’s renowned fall foliage while paying 
tribute to all the other colors and experiences state residents and visitors can enjoy in 
Connecticut this autumn – from the golds of corn mazes and the pinks of cotton candy to 
the blues of coastline sails and the ambers of craft beer. https://portal.ct.gov/Office-of-
the-Governor/News/Press-Releases/2021/09-2021/Governor-Lamont-Announces-
Launch-of-Full-Color-Connecticut-Campaign-Promoting-Fall-Tourism-Season  
• Governor Ned Lamont issued Executive Order No. 13G, which replaces and clarifies his 
previous Executive Order No. 13D. The order does not change the substance or 
timelines of the previous order and still requires that all Connecticut state employees 
and staff of all childcare facilities and preK-12 schools statewide receive at least one 
dose of a COVID-19 vaccine by September 27, 2021. Those who do not get vaccinated 
due to certain exemptions will be required to test for COVID-19 on a weekly basis. 
However, state hospital and long-term care employees do not have the option of testing 







Local Updates  
 
New York Blood Center (NYBC) 
 
For the latest updated NYBC information about COVID-19: 
https://nybc.org/covid-19/  
 
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)   
 
NYC DOHMH launched a new variants data page. The data on this page show how variants of the 
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain 
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more 
severe or able to avoid antibodies from vaccines or previous infections. 
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page  
 
For NYC DOHMH updated COVID-19 data page 
https://www1.nyc.gov/site/doh/covid/covid-19-data.page  
 
For the latest COVID-19 information from NYC DOHMH 
https://www1.nyc.gov/site/doh/covid/covid-19-main.page  
 
Westchester County Department of Health 
  
For the latest breakdown of positive cases in Westchester County as of September 12, 2021 
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d  
 
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams 
offering earlier access to vaccines. 
https://health.westchestergov.com/2019-novel-coronavirus   
 
Putnam County Department of Health 
Breakdown of positive cases by towns in Putnam County as of September 9, 2021- 
https://www.putnamcountyny.com/covid19/ 
 
For the latest COVID-19 information 
https://www.putnamcountyny.com/health/coronavirus/ 
 
Dutchess County Department of Health 
 
Breakdown of positive cases in Dutchess County as of September 13, 2021 
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm  
 
For the latest COVID-19 information: 
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm 
 
Orange County Department of Health   
 
Updated COVID-19 dashboard for Orange County, NY as of September 13, 2021 
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71 
 




Rockland County Department of Health 
 
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of 
September 13, 2021 
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096  
 






For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital 




Center for Disaster Medicine Media 
 
Faculty News: 
A Reflection from the Front Lines 
Journal of Emergency Medical Services 
9/11/2021 
https://www.jems.com/commentary/a-reflection-from-the-front-lines/ 
George W. Contreras, M.E.P., M.P.H., M.S., CEM, FAcEM, assistant director of the Center for 
Disaster Medicine and assistant professor in the Institute of Public Health  
New York Medical College Leadership News: 




Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice 
president of government affairs 
 




Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice 
president of government affairs 
 
 
Every effort is made to provide accurate and complete information in this newsletter. However, New 
York Medical College cannot guarantee that there will be no errors. NYMC makes no claims, promises or 
guarantees about the accuracy, completeness, or adequacy of the contents of the newsletters or the 
articles linked herein and further expressly disclaims liability for errors and omissions in the contents of 
this newsletter.  
 
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the 







New York Medical College 
Center for Disaster Medicine 
7 Dana Road Suite 511 
Valhalla, New York 10595 
914-594-1750 
https://www.nymc.edu/center-for-disaster-medicine/ 
 
 
 
 
 
 
